|
시장보고서
상품코드
1890930
구강 점막염 시장 : 원인별, 치료법별, 약제 유형별, 중증도별, 환자 유형별, 유통경로별, 최종사용자별, 지역별Oral Mucositis Market, By Cause, By Treatment Type, By Drug Type, By Severity Grade, By Patient Type, By Distribution Channel, By End User, By Geography |
||||||
구강 점막염 시장은 2025년에 17억 2,000만 달러로 추정되며, 2032년까지 28억 4,000만 달러에 달할 것으로 예측됩니다. 2025-2032년 CAGR 7.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 커버 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2024년 | 2025년 시장 규모 : | 17억 2,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2025-2032년 |
| 예측 기간인 2025-2032년의 CAGR : | 7.40% | 2032년에서 예측 가치 : | 28억 4,000만 달러 |
세계 구강점막염 시장은 제약 및 헬스케어 산업에서 중요한 부분을 차지하고 있으며, 전 세계 수백만 명의 환자들에게 영향을 미치는 미충족 수요를 충족시키고 있습니다. 구강점막염은 구강 내를 덮고 있는 점막의 고통스러운 염증과 궤양을 특징으로 하며, 주로 화학요법, 방사선요법, 표적치료제 등 암 치료의 심각한 부작용으로 발생합니다. 이 쇠약해지는 병증은 치료 요법의 강도와 기간에 따라 치료받는 암 환자의 약 40-100%에게 영향을 미칩니다.
본 시장은 구강점막염의 중증도, 지속기간, 합병증을 줄이기 위한 예방책, 지지요법 제품, 혁신적인 치료법 등 다양한 치료 접근법을 포괄하고 있습니다. 전 세계 암 환자 증가, 적극적 치료 프로토콜의 보급 확대, 지지요법 관리에 대한 인식 향상으로 본 시장은 종합적인 암 치료의 중요한 구성 요소로 자리매김하고 있습니다. 의료 서비스 프로바이더, 제약회사, 의료기기 제조업체들은 환자의 삶의 질, 치료 순응도, 의료비 지출에 중대한 영향을 미치는 이 질환에 대한 효과적인 솔루션 개발에 점점 더 많은 노력을 기울이고 있습니다.
시장 역학
세계 구강점막염 시장은 주로 전 세계 암 발생률 증가에 의해 주도되고 있습니다. 세계보건기구(WHO)와 같은 기관은 전 세계에서 암 환자가 크게 증가할 것으로 예측하고 있으며, 이는 지지요법 솔루션에 대한 수요 증가와 직접적으로 연관되어 있습니다. 고용량 화학요법 및 복합요법을 포함한 암 치료 프로토콜의 강화로 인해 구강점막염 발생의 심각성과 빈도가 증가함에 따라 치료적 개입에 대한 큰 시장 기회가 창출되고 있습니다. 암 치료에서 지지요법의 중요성에 대한 의료진과 환자들의 인식이 높아지면서 시장 확산이 촉진되고 있으며, 선진국의 의료비 증가와 상환 정책의 개선이 시장 성장을 지원하고 있습니다.
그러나 시장에는 심각한 제약도 존재합니다. 특히 의료 예산이 제한된 신흥 국가에서는 혁신적인 치료 솔루션의 높은 비용으로 인해 접근성이 제한되고 있습니다. 또한 특정 지역의 의료진들의 치료 옵션에 대한 인식 부족과 서로 다른 의료 시스템 간의 표준화된 치료 프로토콜의 부재가 시장 침투를 방해하고 있습니다. 또한 희귀질환 및 특정 질환을 대상으로 하는 의약품에 대한 복잡한 규제 상황이 신규 진입 장벽으로 작용하여 제품 승인 지연을 초래하고 있습니다. 그러나 생물제제, 표적치료제, 혁신적인 전달 시스템 등 새로운 치료 효과와 환자 순응도 향상을 약속하는 치료법 개발을 통해 큰 기회가 존재합니다. 새로운 화학요법제 및 면역요법을 포함한 종양학 파이프라인의 확대는 관련 지지요법 제품에 대한 기회를 가져다 줄 것입니다. 또한 연구개발에 대한 투자 증가, 맞춤형 의료 접근법에 대한 관심 증가, 병용요법의 가능성은 이 중요한 미충족 의료 수요에 대응하는 시장 진출기업에게 큰 성장 기회를 제공할 것입니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 예측 기간(2025-2032년)의 연평균 성장률(CAGR)을 나타내는 세계 구강 점막염 시장에 대한 상세한 분석 정보를 제공합니다.
- 또한 다양한 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 시장 성장 촉진요인, 제약요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계 구강 점막염 치료제 시장의 주요 기업 개요을 제공합니다.
- 이 보고서는 마케팅 담당자 및 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 구강 점막염 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자들은 세계 구강점막염 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 리포트 개요
- 시장 정의와 범위
- 개요
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수의 동향
- 업계 동향
제4장 세계의 구강 점막염 시장 : 원인별, 2020-2032년
- 화학요법 유발 구강 점막염
- 방사선 요법 유발 구강 점막염
- 조혈모세포 이식 유발 구강 점막염
- 기타 원인
제5장 세계의 구강 점막염 시장 : 치료법별, 2020-2032년
- 배리어제/코팅제(젤, 마우스워시, 스프레이, 필름)
- 진통제 및 마취제(국소 진통제, 국소 마취제)
- 항염증약(스테로이드계, 비스테로이드계)
- 항균제(항진균제, 항균제)
- 성장 요인(Palifermin)
- 냉동요법 기기(구강내 냉동요법 기기)
- 식이보충제(경구 영양보충제)
- 기타
제6장 세계의 구강 점막염 치료제 시장 : 약제 유형별, 2020-2032년
- 저분자 의약품
- 생물제제
- 바이오시밀러
제7장 세계의 구강 점막염 시장 : 중증도별, 2020-2032년
- 경도(등급 1-2)
- 고도(등급 3-4)
제8장 세계의 구강 점막염 시장 : 환자 유형별, 2020-2032년
- 소아
- 성인
- 고령자
제9장 세계의 구강 점막염 시장 : 유통경로별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제10장 세계의 구강 점막염 치료제 시장 : 최종사용자별, 2020-2032년
- 병원
- 치과의원
- 종양 전문 병원
- 연구기관 및 학술기관
- 재택 의료 환경
제11장 세계의 구강 점막염 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제12장 경쟁 구도
- Amgen Inc
- Helsinn Healthcare SA
- Bausch Health Companies Inc
- Spectrum Pharmaceuticals Inc
- BioAlliance Pharma SA
- STADA Arzneimittel AG
- Soligenix Inc
- OraPharma Inc
- Innovation Pharmaceuticals Inc
- EpicentRx Inc
- Galera Therapeutics Inc
- Pfizer Inc
- Merck &Co
- Biocon Limited
- OncoZenge AB
제13장 애널리스트의 권장사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제14장 참고 문헌 및 조사 방법
- 참고 문헌
- 조사 방법
- 출판사 소개
Oral Mucositis Market is estimated to be valued at USD 1.72 Bn in 2025 and is expected to reach USD 2.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.72 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.40% | 2032 Value Projection: | USD 2.84 Bn |
The global oral mucositis market represents a critical segment within the pharmaceutical and healthcare industry, addressing a significant unmet medical need affecting millions of patients worldwide. Oral mucositis, characterized by painful inflammation and ulceration of the mucous membranes lining the oral cavity, primarily occurs as a severe side effect of cancer treatments including chemotherapy, radiation therapy, and targeted therapies. This debilitating condition affects approximately 40-100% of cancer patients undergoing treatment, depending on the therapeutic regimen's intensity and duration.
The market encompasses various therapeutic approaches including preventive measures, supportive care products, and innovative treatment modalities designed to reduce the severity, duration, and associated complications of oral mucositis. The growing global cancer burden, increasing adoption of aggressive cancer treatment protocols, and rising awareness about supportive care management have positioned this market as a vital component of comprehensive oncology care. Healthcare providers, pharmaceutical companies, and medical device manufacturers are increasingly focusing on developing effective solutions to address this condition, which significantly impacts patient quality of life, treatment compliance, and overall healthcare costs.
Market Dynamics
The global oral mucositis market is primarily driven by the escalating global cancer incidence, with organizations like the World Health Organization projecting significant increases in cancer cases worldwide, directly correlating with higher the demand for supportive care solutions. The intensification of cancer treatment protocols, including high-dose chemotherapy regimens and combined modality treatments, has increased the severity and frequency of oral mucositis occurrences, creating substantial market opportunities for therapeutic interventions. Growing awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment has enhanced market adoption, while increasing healthcare expenditure and improved reimbursement policies in developed nations support market growth.
However, the market faces significant restraints including the high cost of innovative therapeutic solutions, which limits accessibility particularly in emerging economies where healthcare budgets remain constrained. Limited awareness about available treatment options among healthcare providers in certain regions, coupled with the lack of standardized treatment protocols across different healthcare systems, hampers market penetration. Additionally, the complex regulatory landscape for pharmaceutical products targeting rare or specific conditions creates barriers for new market entrants and delays product approvals. Nevertheless, substantial opportunities exist through the development of novel therapeutic approaches including biologics, targeted therapies, and innovative delivery systems that promise enhanced efficacy and patient compliance. The expanding oncology pipeline with new chemotherapy agents and immunotherapies presents opportunities for companion supportive care products. Furthermore, increasing investments in research and development, growing focus on personalized medicine approaches, and the potential for combination therapies offer significant growth prospects for market participants in addressing this critical unmet medical need.
Key Features of the Study
- This report provides in-depth analysis of the global oral mucositis market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oral mucositis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc, Helsinn Healthcare SA, Bausch Health Companies Inc, Spectrum Pharmaceuticals Inc, BioAlliance Pharma SA, STADA Arzneimittel AG, Soligenix Inc, OraPharma Inc, Innovation Pharmaceuticals Inc, EpicentRx Inc, Galera Therapeutics Inc, Pfizer Inc, Merck & Co, Biocon Limited, and OncoZenge AB
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global oral mucositis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral mucositis market
Market Segmentation
- Cause Insights (Revenue, USD Bn, 2020 - 2032)
- Chemotherapy-Induced Oral Mucositis
- Radiotherapy-Induced Oral Mucositis
- Hematopoietic Stem Cell Transplantation-Induced Oral Mucositis
- Other Causes
- Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
- Barrier/Coating Agents (Gels, Mouthwashes, Sprays, Films)
- Analgesics and Anesthetics (Topical Analgesics, Topical Anesthetics)
- Anti-Inflammatory Agents (Steroidal, Non-Steroidal)
- Antimicrobials (Antifungals, Antibacterials)
- Growth Factors (Palifermin)
- Cryotherapy Devices (Intraoral Cryotherapy Devices)
- Nutritional Support Products (Oral Nutritional Supplements)
- Others
- Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule Drugs
- Biologics
- Biosimilars
- Severity Grade Insights (Revenue, USD Bn, 2020 - 2032)
- Mild (Grade 1-2)
- Severe (Grade 3-4)
- Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Dental Clinics
- Oncology Hospitals
- Research and Academic Institutes
- Homecare Settings
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc
- Helsinn Healthcare SA
- Bausch Health Companies Inc
- Spectrum Pharmaceuticals Inc
- BioAlliance Pharma SA
- STADA Arzneimittel AG
- Soligenix Inc
- OraPharma Inc
- Innovation Pharmaceuticals Inc
- EpicentRx Inc
- Galera Therapeutics Inc
- Pfizer Inc
- Merck & Co
- Biocon Limited
- OncoZenge AB
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Oral Mucositis Market, By Cause
- Global Oral Mucositis Market, By Treatment Type
- Global Oral Mucositis Market, By Drug Type
- Global Oral Mucositis Market, By Severity Grade
- Global Oral Mucositis Market, By Patient Type
- Global Oral Mucositis Market, By Distribution Channel
- Global Oral Mucositis Market, By End User
- Global Oral Mucositis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Oral Mucositis Market, By Cause, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Chemotherapy-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Radiotherapy-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematopoietic Stem Cell Transplantation-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Causes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Oral Mucositis Market, By Treatment Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Barrier/Coating Agents (Gels, Mouthwashes, Sprays, Films)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analgesics and Anesthetics (Topical Analgesics, Topical Anesthetics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anti-Inflammatory Agents (Steroidal, Non-Steroidal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antimicrobials (Antifungals, Antibacterials)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Growth Factors (Palifermin)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cryotherapy Devices (Intraoral Cryotherapy Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nutritional Support Products (Oral Nutritional Supplements)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Oral Mucositis Market, By Drug Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Small Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Oral Mucositis Market, By Severity Grade, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mild (Grade 1-2)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Severe (Grade 3-4)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Oral Mucositis Market, By Patient Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Oral Mucositis Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Oral Mucositis Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dental Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Oral Mucositis Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cause, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Helsinn Healthcare SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch Health Companies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Spectrum Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioAlliance Pharma SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STADA Arzneimittel AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Soligenix Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OraPharma Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Innovation Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EpicentRx Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Galera Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocon Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OncoZenge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
